1. Role of miR‐218‐GREM1 axis in epithelial‐mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data
    Yanpeng Wang et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
  2. Tumor Suppressor microRNAs in Gastrointestinal Cancers: A Mini-Review
    Ganesan Jothimani et al, 2022, Recent Advances in Inflammation & Allergy Drug Discovery CrossRef
  3. Noncoding RNA Expression Aberration Is Associated with Cancer Progression and Is a Potential Biomarker in Esophageal Squamous Cell Carcinoma
    Hidetaka Sugihara et al, 2015, International Journal of Molecular Sciences CrossRef
  4. MicroRNAs in esophageal squamous cell carcinoma: Application in prognosis, diagnosis, and drug delivery
    Elahe Mohammadi et al, 2022, Pathology - Research and Practice CrossRef
  5. MicroRNAs’ role in the environment-related non-communicable diseases and link to multidrug resistance, regulation, or alteration
    Marwa M. Mahmoud et al, 2021, Environmental Science and Pollution Research CrossRef
  6. MicroRNA-218 regulates cisplatin (DPP) chemosensitivity in non-small cell lung cancer by targeting RUNX2
    Jing Xie et al, 2016, Tumor Biology CrossRef
  7. LncRNAs and miRNAs participate in determination of sensitivity of cancer cells to cisplatin
    Mohammad Taheri et al, 2021, Experimental and Molecular Pathology CrossRef
  8. The role of microRNAs in gallbladder cancer
    GANGHUA YANG et al, 2016, Molecular and Clinical Oncology CrossRef
  9. miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN
    KAI LIU et al, 2015, Oncology Reports CrossRef
  10. Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer
    Wanli Yang et al, 2017, Expert Review of Gastroenterology & Hepatology CrossRef
  11. Novel fourth generation-like CARmiR cells release therapeutic miRNA via exosomes and enhance glioblastoma cell killing activity
    Amar Yeware et al, 2023, Biochemical Engineering Journal CrossRef
  12. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review
    Ya-Kai Huang, 2015, World Journal of Gastroenterology CrossRef
  13. A method for establishing a patient-derived xenograft model to explore new therapeutic strategies for esophageal squamous cell carcinoma
    YANAN JIANG et al, 2016, Oncology Reports CrossRef
  14. MicroRNA-101 sensitizes hepatocellular carcinoma cells to doxorubicin-induced apoptosis via targeting Mcl-1
    HAIFEI HE et al, 2016, Molecular Medicine Reports CrossRef
  15. Upregulation of sine oculis homeobox homolog 3 is associated with proliferation, invasion, migration, as well as poor prognosis of esophageal cancer
    Jie Du, 2019, Anti-Cancer Drugs CrossRef
  16. In silico prediction of potential miRNA‐disease association using an integrative bioinformatics approach based on kernel fusion
    Na‐Na Guan et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
  17. Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer
    Ling Wei et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  18. What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?
    Gaia Palmini et al, 2017, Molecules CrossRef
  19. RETRACTED ARTICLE: Downregulation of miR-185 and upregulation of miR-218 expression may be potential diagnostic and prognostic biomarkers of human chondrosarcoma
    Peyman Karimi Goudarzi et al, 2016, Tumor Biology CrossRef
  20. MiR-218 increases sensitivity to cisplatin in esophageal cancer cells via targeting survivin expression
    Lin Jingjing et al, 2016, Open Medicine CrossRef
  21. Emerging Role of MicroRNAs in mTOR Signaling
    Yanjie Zhang et al, 2017, Cellular and Molecular Life Sciences CrossRef
  22. FGF2 regulates proliferation, migration, and invasion of ECA109 cells through PI3K/Akt signalling pathway in vitro
    Hui Shi et al, 2016, Cell Biology International CrossRef
  23. microRNA‐10b confers cisplatin resistance by activating AKT/mTOR/P70S6K signaling via targeting PPARγ in esophageal cancer
    Kai Wu et al, 2020, Journal of Cellular Physiology CrossRef
  24. MicroRNA-218 promotes cisplatin resistance in oral cancer via the PPP2R5A/Wnt signaling pathway
    Zehang Zhuang et al, 2017, Oncology Reports CrossRef